Clinical Trials Logo

Citation(s)

  •   Blackmore KM, Knight JA, Jong R, Lilge L
    Assessing breast tissue density by transillumination breast spectroscopy (TIBS): an intermediate indicator of cancer risk. Br J Radiol. 2007 Jul;80(955):545-56. Epub 2007 May 30.
  •   Blyschak K, Simick M, Jong R, Lilge L
    Classification of breast tissue density by optical transillumination spectroscopy: optical and physiological effects governing predictive value. Med Phys. 2004 Jun;31(6):1398-414.
  •   Simick MK, Jong R, Wilson B, Lilge L
    Non-ionizing near-infrared radiation transillumination spectroscopy for breast tissue density and assessment of breast cancer risk. J Biomed Opt. 2004 Jul-Aug;9(4):794-803.
  •   Simick MK, Lilge L
    Optical transillumination spectroscopy to quantify parenchymal tissue density: an indicator for breast cancer risk. Br J Radiol. 2005 Nov;78(935):1009-17.

Transillumination for Breast Cancer Risk Assessment

Details for clinical trial NCT00188721